Search

Your search keyword '"Trojan, Jörg"' showing total 60 results

Search Constraints

Start Over You searched for: Author "Trojan, Jörg" Remove constraint Author: "Trojan, Jörg" Database OAIster Remove constraint Database: OAIster
60 results on '"Trojan, Jörg"'

Search Results

1. Phantom limb pain after unilateral arm amputation is associated with decreased heat pain thresholds in the face

2. Efficacy and safety of atezolizumab and bevacizumab in the real-world treatment of advanced hepatocellular carcinoma: Experience from four tertiary centers

3. Low platelet count predicts reduced survival in potentially resectable hepatocellular carcinoma

4. Assessing the impact of COVID-19 on liver cancer management (CERO-19)

5. Complete Pathological Response After Neoadjuvant Short-Course Immunotherapy with Ipilimumab and Nivolumab in Locally Advanced MSI-H/dMMR Rectal Cancer

6. Complete pathological response after neoadjuvant short-course immunotherapy with Ipilimumab and Nivolumab in locally advanced MSI-H/dMMR rectal cancer

7. Comparative efficacy of cabozantinib and ramucirumab after sorafenib for patients with hepatocellular carcinoma and alpha-fetoprotein ≥ 400 ng/ml : a matching-adjusted indirect comparison

8. Combination of sorafenib and transarterial chemoembolization in selected patients with advanced-stage hepatocellular carcinoma: a retrospective cohort study at three german liver centers

9. Publisher Correction: The Scales Project, a cross-national dataset on the interpretation of thermal perception scales.

10. Evaluating assumptions of scales for subjective assessment of thermal environments – Do laypersons perceive them the way, we researchers believe?

11. Publisher Correction: The Scales Project, a cross-national dataset on the interpretation of thermal perception scales.

12. Evaluating assumptions of scales for subjective assessment of thermal environments – Do laypersons perceive them the way, we researchers believe?

13. Evaluating assumptions of scales for subjective assessment of thermal environments – Do laypersons perceive them the way, we researchers believe?

14. Publisher Correction:The Scales Project, a cross-national dataset on the interpretation of thermal perception scales

15. Evaluating assumptions of scales for subjective assessment of thermal environments – Do laypersons perceive them the way, we researchers believe?

16. Publisher Correction:The Scales Project, a cross-national dataset on the interpretation of thermal perception scales

17. Cetuximab-mediated protection from hypoxia-induced cell death: implications for therapy sequence in colorectal cancer

18. Photochemical internalization and gemcitabine combined with first-line chemotherapy in perihilar cholangiocarcinoma: observations in three patients

19. AFP ratio predicts HCC recurrence after liver transplantation

20. Evaluating assumptions of scales for subjective assessment of thermal environments – Do laypersons perceive them the way, we researchers believe?

21. Evaluating assumptions of scales for subjective assessment of thermal environments – Do laypersons perceive them the way, we researchers believe?

22. Evaluating assumptions of scales for subjective assessment of thermal environments – Do laypersons perceive them the way, we researchers believe?

23. Evaluating assumptions of scales for subjective assessment of thermal environments – Do laypersons perceive them the way, we researchers believe?

24. Cabozantinib for the treatment of advanced hepatocellular carcinoma: current data and future perspectives

25. The Scales Project, a cross-national dataset on the interpretation of thermal perception scales.

26. The Scales Project, a cross-national dataset on the interpretation of thermal perception scales

27. The Scales Project, a cross-national dataset on the interpretation of thermal perception scales.

28. The Scales Project, a cross-national dataset on the interpretation of thermal perception scales

29. The Scales Project, a cross-national dataset on the interpretation of thermal perception scales

30. Evaluation of EGFR inhibitor‐mediated acneiform skin toxicity within the double‐blind randomized EVITA trial: A thorough gender‐specific analysis using the WoMo score

31. Sarcopenia as a prognostic factor for survival in patients with locally advanced gastroesophageal adenocarcinoma

32. The Scales Project, a cross-national dataset on the interpretation of thermal perception scales

33. The Scales Project, a cross-national dataset on the interpretation of thermal perception scales

34. The Scales Project, a cross-national dataset on the interpretation of thermal perception scales

35. The Scales Project, a cross-national dataset on the interpretation of thermal perception scales

36. The restorative value of the urban environment: A systematic review of the literature.

37. Vitamin K1 cream significantly reduces incidence and severity of cetuximab-related acneiform skin rash in women: a post hoc analysis of the EVITA trial

38. Circulating hypoxia marker carbonic anhydrase IX (CA9) in patients with hepatocellular carcinoma and patients with cirrhosis

39. Prognostic value of the neutrophil-to-lymphocyte ratio in the ARQ 197-215 second-line study for advanced hepatocellular carcinoma.

40. Bevacizumab-based first-line chemotherapy in elderly patients with metastatic colorectal cancer : an individual patient data based meta-analysis

41. Clinical application of liquid biopsy in targeted therapy of metastatic colorectal cancer

42. Prognostic value of the neutrophil-to-lymphocyte ratio in the ARQ 197-215 second-line study for advanced hepatocellular carcinoma

43. Prognostic value of the neutrophil-to-lymphocyte ratio in the ARQ 197-215 second-line study for advanced hepatocellular carcinoma

44. Prognostic value of the neutrophil-to-lymphocyte ratio in the ARQ 197-215 second-line study for advanced hepatocellular carcinoma

45. Tumor and circulating biomarkers in patients with second-line hepatocellular carcinoma from the randomized phase II study with tivantinib.

46. Krebs. Länger leben mit Immuntherapie : Checkpoint-Inhibitoren machen Krebszellen für das Immunsystem sichtbar

47. Tumor and circulating biomarkers in patients with second-line hepatocellular carcinoma from the randomized phase II study with tivantinib

48. Tumor and circulating biomarkers in patients with second-line hepatocellular carcinoma from the randomized phase II study with tivantinib

49. Endothelial cell-derived angiopoietin-2 is a therapeutic target in treatment-naive and bevacizumab-resistant glioblastoma

50. Panitumumab use in metastatic colorectal cancer and patterns of KRAS testing : results from a Europe-wide physician survey and medical records review

Catalog

Books, media, physical & digital resources